Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Index
-
Market Cap
88.90M
Enterprise Value
68.65M
Income
-253.50M
Sales
3.26M
Book/sh
2.99
Cash/sh
1.89
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
14
IPO
Apr 09, 2010
P/E
-
Forward P/E
-
PEG
-
P/S
27.27
P/B
2.56
P/C
4.06
P/FCF
-
EV/EBITDA
-
EV/Sales
21.06
Quick Ratio
1.45
Current Ratio
1.45
Debt/Eq
0.05
LT Debt/Eq
0.02
Option/Short
No / Yes
EPS (ttm)
-145.45
EPS next Y
-0.11
EPS next Q
-0.29
EPS this Y
-169.89%
EPS next Y
93.68%
EPS next 5Y
-
EPS past 3/5Y
49.83% 54.21%
Sales past 3/5Y
-56.34% -36.90%
EPS Y/Y TTM
-591.53%
Sales Y/Y TTM
204.84%
EPS Q/Q
74.37%
Sales Q/Q
119772.93%
Insider Own
32.19%
Insider Trans
0.24%
Inst Own
4.25%
Inst Trans
1.85%
ROA
-488.39%
ROE
-1565.24%
ROIC
-733.09%
Gross Margin
-14.84%
Oper. Margin
-953.64%
Profit Margin
-7770.02%
SMA20
-25.43%
SMA50
-27.59%
SMA200
16.64%
Trades
Shs Outstand
11.38M
Shs Float
7.86M
52W High
13.49 -43.14%
52W Low
1.03 644.66%
Volatility
9.82% 10.06%
ATR (14)
1.00
RSI (14)
34.53
Beta
3.83
Rel Volume
0.40
Avg Volume
406.28K
Volume
106,068
Perf Week
-0.13%
Perf Month
-32.42%
Perf Quarter
6.38%
Perf Half Y
15.51%
Perf YTD
7.27%
Perf Year
-9.55%
Perf 3Y
-84.02%
Perf 5Y
-97.95%
Perf 10Y
-99.91%
Prev Close
7.77
Price
7.67
Change %
-1.29%
Date Action Analyst Rating Change Price Target Change
Aug-19-24Initiated H.C. Wainwright Buy $3
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Zhu TheodoreDirectorSep 08 '26Buy11.248,75098,32516,314Sep 09 07:09 PM
Axe Compute, Inc. engages in the provision of graphics processing unit compute capacity for artificial intelligence and other complex computing workloads. It operates through the following segments: Compute Services and Treasury Management segment, and Drug Discovery Services segment. The Compute Services and Treasury Management segment provides services that include access to GPU compute capacity and manage the ATH Treasury Strategy. The Drug Discovery Services segment provides services that include the application of AI, creation of specific 3D culture models used in drug development. The company was founded by Lawrence W. Gadbaw, Peter L. Morawetz, and Jeffrey K. Drogue on April 23, 2002 and is headquartered in Pittsburgh, PA.
CEO & DirectorMr. Christopher Miglino
PresidentMr. Kyle Okamoto
Chief Financial OfficerMr. Jeremy Yaukey-Witter
Vice President of Marketing & Investor RelationsErin McMahon
General CounselMs. Sara Turken J.D.